Print this page    •   Back to Web version of article

International News
Mylan Subsidiary Starts Operations in India

August 9, 2012

Pennsylvania-based Mylan Inc. said a subsidiary has launched commercial operations in India, beginning with HIV/AIDS drugs. After initially offering 18 antiretrovirals, Mylan Pharmaceuticals Private Ltd. plans to add therapeutic categories and enlarge its sales force. Mylan already is active in the nation, having acquired a majority stake in Matrix Laboratories of India in 2007 and bought the remainder of the company in 2009. India is home to the world's third-largest population of HIV/AIDS patients, according to the National AIDS Control Organization.

Back to other news for August 2012

Excerpted from:
Associated Press

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.